| Literature DB >> 15811830 |
Joan Reibman1, Shao Lin, Syni-An A Hwang, Mridu Gulati, James A Bowers, Linda Rogers, Kenneth I Berger, Anne Hoerning, Marta Gomez, Edward F Fitzgerald.
Abstract
The destruction of the World Trade Center (WTC) on 11 September 2001 in New York City resulted in the massive release of pulverized dust and combustion products. The dust and smoke settled in the surrounding area, which encompassed a large residential community. We hypothesized that previously normal residents in the community surrounding the former WTC would have an increased incidence of persistent respiratory symptoms and abnormalities in screening spirometry. A hybrid cross-sectional and retrospective cohort study using a symptom-based questionnaire and onsite screening spirometry in residents in an exposed area and in a control area was performed 12 +/- 4 months after the collapse. Surveys were analyzed from 2,812 residents. New-onset respiratory symptoms were described by 55.8% of residents in the exposed area, compared with 20.1% in the control area after the event. Persistent new-onset symptoms were identified in 26.4 versus 7.5% of residents in the exposed area versus control area, respectively. No differences in screening spirometry between the groups were detected. A small pilot study suggested the possibility of an increase in bronchial hyperresponsiveness in exposed participants with persistent symptoms. The data demonstrate an increased rate of new-onset and persistent respiratory health effects in residents near the former WTC compared with a control population.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15811830 PMCID: PMC1278479 DOI: 10.1289/ehp.7375
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Study cohort classifications. Previously normal residents were considered to be those who did not have a physician diagnosis of asthma, chronic obstructive pulmonary disease, or emphysema before 11 September 2001.
Demographics of resident respondents (percentage) to the WTC Residents’ Respiratory Health Study.
| Characteristic | Exposed ( | Control ( | |
|---|---|---|---|
| Sex | |||
| Male/female | 38.0/62.0 | 41.3/58.7 | 0.3056 |
| Age (years) | |||
| 0–34 | 23.4 | 23.8 | |
| 35–64 | 51.7 | 35.9 | < 0.0001 |
| ≥65 | 24.9 | 40.3 | |
| Household income | |||
| < $24,999 | 33.4 | 20.3 | |
| $25,000–49,999 | 18.3 | 19.8 | 0.0004 |
| $50,000–99,999 | 23.6 | 30.4 | |
| ≥$100,000 | 24.6 | 29.5 | |
| Race/ethnicity | |||
| White | 61.7 | 79.3 | < 0.0001 |
| Hispanic | 13.7 | 7.5 | 0.0038 |
| Asian | 16.4 | 3.2 | < 0.0001 |
| African American | 8.2 | 11.8 | 0.0439 |
| Other | 4.5 | 4.4 | 0.9515 |
| Education | |||
| < High school | 19.6 | 10.8 | 0.0004 |
Race/ethnicity groups are not mutually exclusive and therefore do not add to 100%.
New-onset respiratory symptoms (percentage) in previously normal residents.
| Symptom | Exposed ( | Control ( | Crude IR (95% CI) |
|---|---|---|---|
| Any cough without cold | 40.6 | 12.1 | 3.36 (2.38–4.74) |
| Nighttime cough | 36.7 | 11.7 | 3.15 (2.21–4.48) |
| Wheeze | 28.4 | 6.6 | 4.32 (2.68–6.98) |
| Daytime SOB | 27.2 | 10.4 | 2.62 (1.80–3.83) |
| Morning chest tightness | 23.7 | 7.9 | 3.00 (2.15–6.94) |
| SOB after exercise | 18.1 | 4.7 | 3.86 (2.15–6.94) |
| Nighttime SOB | 15.8 | 4.5 | 3.48 (1.94–6.25) |
| Any of the above symptoms | 55.8 | 20.1 | 2.78 (2.17–3.56) |
No diagnosis of asthma, chronic obstructive pulmonary disease, chronic bronchitis, or other lung disease before 11 September 2001.
*Effect still statistically significant after adjusting for age, sex, education, smoking, and race.
Persistent new-onset respiratory symptoms (percentage) in previously normal residents.
| Symptom | Exposed ( | Control ( | Crude IR (95% CI) |
|---|---|---|---|
| Cough without cold | 16.0 | 4.0 | 3.99 (2.15–7.38) |
| Nighttime cough | 12.9 | 3.7 | 3.51 (1.83–6.72) |
| Wheeze | 10.5 | 1.6 | 6.50 (2.44–17.33) |
| Daytime SOB | 10.6 | 3.6 | 2.94 (1.53–5.66) |
| Morning chest tightness | 8.4 | 1.6 | 5.21 (1.95–13.91) |
| SOB after exercise | 7.4 | 1.7 | 4.45 (1.66–11.91) |
| Nighttime SOB | 6.2 | 0.8 | 7.64 (1.90–30.70) |
| Any of the above symptoms | 26.4 | 7.5 | 3.53 (2.28–5.47) |
Symptom frequency ≥2 days per week in the past 4 weeks.
*Effect still statistically significant after adjusting for age, sex, education, smoking, and race.
Frequency (percentage) of specific symptoms in residents with persistent new-onset respiratory symptoms.
| Symptom | Never | < 2 days/week | 2–6 days/week | Daily |
|---|---|---|---|---|
| Cough without cold | 15.2 | 21.4 | 40.0 | 23.5 |
| Nighttime cough | 24.3 | 23.5 | 36.2 | 15.9 |
| Daytime SOB | 28.7 | 25.3 | 28.2 | 17.8 |
| Wheeze | 34.7 | 22.3 | 25.5 | 17.5 |
| Morning chest tightness | 41.9 | 20.4 | 27.5 | 10.2 |
| SOB after exercise | 44.1 | 19.7 | 24.3 | 11.8 |
| Nighttime SOB | 52.3 | 20.6 | 19.2 | 7.9 |
Screening spirometry in previously normal residents with persistent new-onset respiratory symptoms (mean ± SD).
| Exposed persistent symptoms ( | Exposed asymptomatic ( | Control asymptomatic ( | |
|---|---|---|---|
| FEV1 (percent predicted) | 91.4 ± 12.1 | 95.4 ± 14.0 | 93.0 ± 11.9 |
| FVC (percent predicted) | 89.6 ± 12.2 | 94.3 ± 14.7 | 89.9 ± 10.0 |
| FEV1/FVC (%) | 82.1 ± 6.9 | 81.4 ± 4.2 | 83.3 ± 7.1 |
| FEF25–75 (percent predicted) | 90.1 ± 26.6 | 90.0 ± 22.0 | 94.6 ± 34.3 |
| PEF (percent predicted) | 90.2 ± 17.6 | 97.5 ± 15.9 | 93.8 ± 13.4 |
PEF, peak expiratory flow. p-Value > 0.05 for all comparisons.